Structural mechanisms of PIP2 activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1
eLife · 28.05.2025 · 14
DOI: 10.7554/elife.105396 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 28.05.2025. Verfasst von Jing Xue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, United States. Hauptthemen laut MEDLINE: Sodium-Calcium Exchanger, Phosphatidylinositol 4,5-Diphosphate, Phenyl Ethers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Na + /Ca 2+ exchangers (NCXs) transport Ca 2+ across the plasma membrane in exchange for Na + and play a vital role in maintaining cellular Ca 2+ homeostasis. Our previous structural study of human cardiac NCX1 (HsNCX1) reveals the overall architecture of the eukaryotic exchanger and the formation of the inactivation assembly by the intracellular regulatory domain that underlies the cytosolic Na + -dependent inactivation and Ca 2+ activation of NCX1. Here, we present the cryo-EM structures of HsNCX1 in complex with a physiological activator phosphatidylinositol 4,5-bisphosphate (PIP 2 ), or pharmacological inhibitor SEA0400, that enhances the inactivation of the exchanger. We demonstrate that PIP 2 binding stimulates NCX1 activity by inducing a conformational change at the interface between the transmembrane (TM) and cytosolic domains that destabilizes the inactivation assembly. In contrast, SEA0400 binding in the TM domain of NCX1 stabilizes the exchanger in an inward-facing conformation that facilitates the formation of the inactivation assembly, thereby promoting the Na + -dependent inactivation of NCX1. Thus, this study reveals the structural basis of PIP 2 activation and SEA0400 inhibition of NCX1 and provides some mechanistic understandings of cellular regulation and pharmacology of NCX family proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, The University of Texas Southwestern Medical Center, Dallas, United States.
- Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, United States.
- Howard Hughes Medical Institute, Chevy Chase, United States.
- Department of Medicine (Cardiology), UCLA, Los Angeles, United States.
- Department of Anesthesiology and Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States.
ORCID-Profile: Jing Xue, Scott John, Michela Ottolia, Youxing Jiang
Förderung
- NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- Welch Foundation
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Xue, J., Zeng, W., John, S., Attiq, N., Ottolia, M., & Jiang, Y. (2025). Structural mechanisms of PIP2 activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1. eLife, 14. https://doi.org/10.7554/elife.105396
Vancouver
Xue J, Zeng W, John S, Attiq N, Ottolia M, Jiang Y. Structural mechanisms of PIP2 activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1. eLife. 2025;14. doi:10.7554/elife.105396
BibTeX
@article{Xue2025,
author = {Xue, Jing and Zeng, Weizhong and John, Scott and Attiq, Nicole and Ottolia, Michela and Jiang, Youxing},
title = {Structural mechanisms of PIP2 activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.105396}
}
EUVIMED